As of Mar 27
| +0.63 / +0.54%|
The 26 analysts offering 12-month price forecasts for Bayer have a median target of 118.59, with a high estimate of 137.23 and a low estimate of 92.49. The median estimate represents a +2.17% increase from the last price of 116.07.
The current consensus among 27 polled investment analysts is to Buy stock in Bayer. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.